Cytosine

Specifications

71-30-7CAS Number

200-749-5EC Number

6-amino-1H-pyrimidin-2-oneIUPAC Name

C4H5N3OChemical Formula

111.1 g/molMolecular Weight

cytosine; 71-30-7; 4-Amino-2-hydroxypyrimidine; 4-aminopyrimidin-2(1H)-one; Cytosinimine; 2(1H)-Pyrimidinone, 4-amino-; 4-Amino-2(1H)-pyrimidinone; 6-amino-1H-pyrimidin-2-one; DTXSID4044456; NSC-27787; 8J337D1HZY; CHEBI:16040; 4-amino-3h-pyrimidin-2-one; DTXCID2024456; NSC27787; 6-amino-1,2-dihydropyrimidin-2-one; RefChem:5728; 200-749-5; 4-Aminouracil; 6-Aminopyrimidin-2(1h)-One; MFCD00006034; 4-amino-2-pyrimidinol; 4-aminopyrimidin-2-ol; 2(1H)-pyrimidinone, 6-amino-; 4-amino-2-oxo-1,2-dihydropyrimidine; Cytosin; Cyt; AI3-52281; 107646-83-3; 134434-40-5; 107646-84-4; 6-amino-3-hydropyrimidin-2-one; pyrimidine, 4-amino-2-hydroxy-; 4-Amino-1H-pyrimidin-2-one; 4-Aminopyrimidin-2(1H)-one (Cytosine); SMR000857094; EINECS 200-749-5; Lamivudine EP Impurity E; 4-amino-1,2-dihydropyrimidin-2-one; NSC 27787; 2-Pyrimidinol, 1,4-dihydro-4-imino-; aminopyrimidone; UNII-8J337D1HZY; Zytosin; iminopyrimidinone; 134434-39-2; 2(1H)-Pyrimidinone, 3,4-dihydro-4-imino-, (E)- (9CI); 3h-cytosine; 4-Aminopyrimidin-2-(1H)-one; 66460-18-2; 66460-21-7; Cytosine (8CI); Cytosine (Standard); Lamivudine impurity c; Cytosine, >=99%; 2(1H)-Pyrimidinone, 3,4-dihydro-4-imino-, (Z)- (9CI); 2(1H)-Pyrimidinone, 4-amino- (9CI); Lamivudine impurity c rs; CYTOSINE [MI]; 4-amino-pyrimidin-2-ol; 4-Amino-2-oxypyrimidine; 2(1H)-Pyrimidinone, 3,4-dihydro-4-imino-; bmse000180; CYTOSINE [USP-RS]; CYTOSINE [WHO-DD]; Epitope ID:167475; 4-Amino-2(1H)pyrimidone; EC 200-749-5; Gemcitabine impurity A CRS; SCHEMBL4059; SCHEMBL8618; 4-Amino-2(1H)-pyrimidone; 2-Hydroxy-6-amino-pyrimidin; MLS001332635; MLS001332636; CHEMBL15913; SCHEMBL308339; SCHEMBL437958; SCHEMBL437959; SCHEMBL655341; GTPL8490; orb1221421; orb1302527; SCHEMBL4818561; SCHEMBL6547006; SCHEMBL8921275; 2(1H)-Pyrimidinone 4-amino-; SCHEMBL10402537; HY-I0626R; MSK6920; HMS2233N21; HMS3369N05; HMS5083D22; Cytosine, >=99.0% (HPLC); ALBB-021996; HY-I0626; STR01426; Tox21_302139; EBC-06142; EBC-44129; s4893; SBB071711; STK366767; AKOS000120336; AKOS005443393; AKOS015896942; AC-2489; CCG-266052; CS-W020703; FC03781; 2-Pyrimidinol, 1,6-dihydro-6-imino-; CAS-71-30-7; EBC-4562022; SRI-2354-05; NCGC00247019-01; NCGC00255926-01; 66398-98-9; 66460-19-3; BP-20183; Cytosine, Vetec(TM) reagent grade, 99%; NCI60_012445; SY001643; 4-imino-3,4-dihydropyrimidin-2(1H)-one; DB-029615; DB-268893; DB-268963; DB-271170; DB-271171; DB-295125; LAMIVUDINE IMPURITY E [EP IMPURITY]; LAMIVUDINE IMPURITY C [USP IMPURITY]; NS00006844; ST45026865; T4832; EN300-21504; C00380; F036359; Q178425; Lamivudine EP Impurity E; Gemcitabine EP Impurity A; CBA1D098-C5AB-46CE-AAC6-754572886EB2; Z203045338; Cytosine, United States Pharmacopeia (USP) Reference Standard; Cytosine, Pharmaceutical Secondary Standard; Certified Reference Material; Gemcitabine impurity A, European Pharmacopoeia (EP) Reference Standard; 66460-16-0Synonyms